(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 4439.90 | 5786.40 | -23.27 | 4439.90 | 5786.40 | -23.27 | 18217.40 | 16977.50 | 7.30 |
| Other Income | 263.80 | 226.80 | 16.31 | 263.80 | 226.80 | 16.31 | 983.10 | 355.10 | 176.85 |
| PBIDT | 1462.80 | 2390.00 | -38.79 | 1462.80 | 2390.00 | -38.79 | 7106.40 | 5220.60 | 36.12 |
| Interest | 421.60 | 451.40 | -6.60 | 421.60 | 451.40 | -6.60 | 1795.40 | 2202.40 | -18.48 |
| PBDT | 1041.20 | 1938.60 | -46.29 | 1041.20 | 1938.60 | -46.29 | 5164.30 | 3018.20 | 71.11 |
| Depreciation | 399.80 | 376.00 | 6.33 | 399.80 | 376.00 | 6.33 | 1543.80 | 1817.70 | -15.07 |
| PBT | 641.40 | 1562.60 | -58.95 | 641.40 | 1562.60 | -58.95 | 3620.50 | 1200.50 | 201.58 |
| TAX | 158.40 | 562.70 | -71.85 | 158.40 | 562.70 | -71.85 | 1180.00 | 426.60 | 176.61 |
| Deferred Tax | 56.10 | 291.00 | -80.72 | 56.10 | 291.00 | -80.72 | 570.40 | 206.80 | 175.82 |
| PAT | 483.00 | 999.90 | -51.70 | 483.00 | 999.90 | -51.70 | 2440.50 | 773.90 | 215.35 |
| Equity | 138.60 | 136.20 | 1.76 | 138.60 | 136.20 | 1.76 | 138.50 | 136.20 | 1.69 |
| PBIDTM(%) | 32.95 | 41.30 | -20.23 | 32.95 | 41.30 | -20.23 | 39.01 | 30.75 | 26.86 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1932.75 |
| Dr. Reddys Labs. | 1194.00 |
| Cipla | 1463.10 |
| Lupin | 2268.20 |
| Zydus Lifesciences | 1158.30 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: